Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

724 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DNTT-mediated DNA Damage Response Drives Inotuzumab Ozogamicin Resistance in B-cell Acute Lymphoblastic Leukemia.
Escherich CS, Moriyama T, Li Z, Hsiao Y, Yang W, Li Y, Reyes N, Walker M, Budhraja A, Bhatara S, Diaz-Flores E, Stock W, Paietta E, Konopleva MY, Kornblau SM, Litzow MR, Inaba H, Pui CH, Opferman JT, Loh ML, Yu J, O'Brien M, Evans WE, Yang JJ. Escherich CS, et al. Among authors: konopleva my. Blood. 2024 Dec 27:blood.2024026085. doi: 10.1182/blood.2024026085. Online ahead of print. Blood. 2024. PMID: 39791601
A germline FLT3 variant in aplastic anemia.
Amaeshi LC, Sofianidi AA, Shastri A, Goldfinger M, Konopleva M, Verma AK, Chaitowitz M, Mantzaris I. Amaeshi LC, et al. Among authors: konopleva m. Biomark Res. 2025 Jan 7;13(1):4. doi: 10.1186/s40364-024-00717-3. Biomark Res. 2025. PMID: 39773519 Free PMC article.
Therapy for acute myeloid leukemia in older and unfit adults.
Forsberg M, Konopleva M. Forsberg M, et al. Among authors: konopleva m. Haematologica. 2024 Dec 1;109(12):3832-3834. doi: 10.3324/haematol.2024.286233. Haematologica. 2024. PMID: 39618293 Free PMC article. No abstract available.
Anti-leukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models.
Kannan S, Li Y, Baran N, Yang X, Ghotbaldini S, Tatarata QZ, Yoshimura S, Li Z, Hsiao YC, Balachander SB, Andersen CL, Cidado J, Yu J, Jain N, Yang JJ, Konopleva MY. Kannan S, et al. Among authors: konopleva my. Blood Adv. 2024 Nov 19:bloodadvances.2024013423. doi: 10.1182/bloodadvances.2024013423. Online ahead of print. Blood Adv. 2024. PMID: 39561378
Venetoclax plus low intensity chemotherapy for adults with acute lymphoblastic leukemia.
Luskin MR, Shimony S, Keating JH, Winer ES, Garcia JS, Stone RM, Jabbour EJ, Flamand Y, Stevenson K, Ryan JA, Zeng Z, Letai A, Konopleva MY, Jain N, DeAngelo DJ. Luskin MR, et al. Among authors: konopleva my. Blood Adv. 2024 Nov 15:bloodadvances.2024014405. doi: 10.1182/bloodadvances.2024014405. Online ahead of print. Blood Adv. 2024. PMID: 39546748
RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax.
Sango J, Carcamo S, Sirenko M, Maiti A, Mansour H, Ulukaya G, Tomalin LE, Cruz-Rodriguez N, Wang T, Olszewska M, Olivier E, Jaud M, Nadorp B, Kroger B, Hu F, Silverman L, Chung SS, Wagenblast E, Chaligne R, Eisfeld AK, Demircioglu D, Landau DA, Lito P, Papaemmanuil E, DiNardo CD, Hasson D, Konopleva M, Papapetrou EP. Sango J, et al. Among authors: konopleva m. Nature. 2024 Dec;636(8041):241-250. doi: 10.1038/s41586-024-08137-x. Epub 2024 Oct 30. Nature. 2024. PMID: 39478230 Free PMC article.
724 results